Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term immunogenicity up to 10 years after first booster Tick-Borne Encephalitis vaccination in adults
2011-003255-19Phase 4Completed
- Sponsor
- GSK
- Start
- Sep 2011
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of Tick-borne encephalitis vaccine in tick-borne encephalitis (TBE), sponsored by GSK. Started Sep 2011; status: completed.
02
Drugs
Tick-borne encephalitis vaccine
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2011-003255-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003255-19.